Health & Fitness

New study shows the immune system of zebrafish weakens if one parent has been exposed to antibiotics. Antibiotics can have unwanted effects for several generations, researchers discover.

from Top Health News -- ScienceDaily https://ift.tt/R5AaI12

In an analysis of the most recent data available through the CDC, clinical researchers revealed that firearm injuries are now the leading cause of death among children up to age 19, and the racial gap between black and white youth is widening. The article calls for health care workers to recognize this as an epidemiological and public health challenge and to help find solutions.

from Top Health News -- ScienceDaily https://ift.tt/dA1SJox

Fearful events negatively impact the brain. For instance, war veterans often go through post-traumatic stress disorder months after the cessation of the triggering event. Now, the precise mechanism of suppression of such fearful memories has been uncovered. Using a mouse model, the researchers identified the associated biochemical pathways, thus paving the way for the development and clinical evaluation of therapeutic compounds such as KNT-127.

from Top Health News -- ScienceDaily https://ift.tt/sfHNeTr

Data from a study¹ published in April 2022 in JACC: Heart Failure reveals that people with Type 2 diabetes who used omega-3 supplements had a lower incidence of hospitalization with heart failure. Heart failure is a form of heart disease in which the heart experiences ventricular dysfunction.

The heart is separated into four chambers. The bottom two chambers called the ventricles, pump blood to the lungs or the body.² When there is left ventricular failure, a person experiences fatigue and shortness of breath. With right ventricular failure a person may experience abdominal and peripheral fluid buildup.

Heart failure can affect one or both sides of the heart. Experts believe there are more than 15 million new diagnoses of heart failure globally each year.³ In the U.S., more than 600,000 new cases are diagnosed each year. Additionally, it's estimated that 10 times that number of Americans currently have heart failure.

Despite advances in drug therapy, the prognosis continues to remain poor. Individuals with severe heart failure have a mortality rate of up to 60% over one year and up to 30% mortality rate in mild to moderate failure.⁴ Heart failure develops as the ventricles become inefficient. This can happen from a variety of different factors that place excessive demand on the heart.

One factor that can lead to heart failure is long-term, uncontrolled high blood pressure or hormonal disorders such as hyperthyroidism. But, the primary cause of heart failure is coronary artery disease, which reduces the delivery of oxygen and nutrients to the heart muscle. Over time, this leads to impaired function.

There's also a relationship between chronic high blood pressure and coronary artery disease,⁵ which means that high blood pressure may have an effect on the development of heart failure through at least two pathways. The primary focus of the featured study was to evaluate whether an omega-3 supplement could reduce the risk of hospitalization for heart failure in participants with or without Type 2 diabetes.

Omega-3 Supplements Lower Risk of Heart Failure Admission

The data were gathered from the vitamin D and omega-3 trial (VITAL)⁶ that started in 2010. VITAL, the parent trial for this study, engaged 25,871 men and women to evaluate their dietary supplementation of vitamin D3 or omega-3 fatty acids and the impact it had on developing heart disease, stroke or cancer in people who did not have a history of these health conditions.

Participants took the supplements for a five-year intervention phase and researchers have continued with ongoing follow-up. The ancillary study began in 2014, in which the researchers assessed the role that race and Type 2 diabetes had on supplementation with omega-3 fatty acids.

There were four arms to the study.⁷ The first group received 2,000 international units (IU) per day of vitamin D3 and 1 gram per day of fish oil. The researchers compared results against three other groups who received either two placebos, or a placebo for vitamin D or fish oil. The primary outcome measure was new heart failure with hospitalization and the secondary outcome measure was recurrent hospitalization.

When the researchers evaluated the results⁸ they found that omega-3 supplements could reduce hospitalization rate for the first heart failure by 0.69 in participants who had Type 2 diabetes when compared to taking a placebo. They also found that omega-3 effectively reduced recurrent hospitalization in black participants. The results did not show a benefit for individuals who did not have Type 2 diabetes.

However, the researchers did not measure the omega-3 index for these individuals, thus it is difficult to determine if omega-3 levels were low in those who experienced the greatest benefit. There is evidence to suggest from past studies that individuals with Type 2 diabetes have significantly lower omega-3 indices than those who do not have Type 2 diabetes,⁹ suggesting increasing dietary intake may help prevent the condition.

Data¹⁰ also suggests that omega-3 supplementation may help lower inflammatory levels in people with diabetes, which also contributes to better heart health.¹¹

Vitamin D Significant Factor in Heart Failure Outcomes

One arm of the study included participants who took only vitamin D and a placebo to replace omega-3 fatty acids. In this cohort, the researchers did not find that only vitamin D could help reduce hospitalization rates in people with heart failure. However, there is evidence from multiple past studies that vitamin D has a significant effect on protecting heart health.

Data from one study showed an anti-inflammatory effect from vitamin D in patients with congestive heart failure (CHF) suggesting it may serve as “a new anti-inflammatory agent for the future treatment of the disease. Our data provide evidence for the involvement of an impaired vitamin D–parathyroid hormone axis in the progression of CHF.”¹²

Evidence also suggests that vitamin D has an impact on mineral metabolism and myocardial dysfunction in patients with CHF. Researchers wrote in the American Journal of Cardiology that deficiency may be “a contributing factor in the pathogenesis of CHF.”¹³

Epidemiological studies have also provided strong support that vitamin D has cardioprotective effects¹⁴ and data also show that most patients with CHF have insufficient vitamin D levels, lower than 20 ng/mL.¹⁵ Researchers hypothesize that this may be related to the sedentary lifestyle of people with CHF and that insufficient levels contribute to the etiology of the disease.

More data indicated that low concentrations of vitamin D3 contribute to a poor prognosis in patients with heart failure, which may be related to inflammation.¹⁶ Furthermore, deficiency is highly prevalent, including in patients with heart failure and is “a significant predictor of reduced survival.”¹⁷

Researchers found that supplementing with vitamin D was independently associated with a reduction in mortality and that lower vitamin D levels were associated with high body mass index, diabetes, decreased calcium and hemoglobin levels and female gender.¹⁸

Sulfur and Magnesium: Two Crucial Nutrients for Heart Health

Sulfur has been a “forgotten” nutrient and you don't hear it mentioned very often. Yet it's very important for optimal body function and health. You get most of your sulfur from certain proteins in your diet, specifically, those that contain the amino acids methionine, cysteine, cystine, homocysteine, homocystine and taurine.¹⁹ Of these, the two most important are methionine and cysteine.

Neither of these is stored in the body, although glutathione is a key storage form of sulfur.²⁰ Glutathione keeps many other antioxidants performing at peak levels and cysteine availability is thought to be a rate-limiting factor for glutathione synthesis.²¹ According to Stephanie Seneff, Ph.D., who has written several papers on sulfur,^22,23,24 deficiency appears to play a role in a wide range of health problems and diseases, including heart disease.

In 2011, during an interview with Seneff,²⁵ we discussed the influence that sulfur has on health and disease. She talked about the crucial connections between sulfur, cholesterol and vitamin D, suggesting that sensible sun exposure plays an important role in heart and cardiovascular health as it regulates not only vitamin D3 but also cholesterol sulfate in circulation.

Magnesium also plays a crucial role in high blood pressure and cardiovascular disease. Because serum magnesium is not a reflection of the total amount your body has available, experts believe that most cases of deficiency go undiagnosed.²⁶ Additionally, because of a decrease of magnesium in the soil, medications and the number of processed foods eaten by the majority of people, many are at risk for deficiency.

Low levels of magnesium have been associated with Type 2 diabetes, high blood pressure, atherosclerotic vascular disease and sudden cardiac death.²⁷ Some estimates are that nearly half the U.S. population eats less than the required amount of magnesium-rich food and that the prevalence and incidence of Type 2 diabetes rose while consumption of magnesium declined.

Magnesium is a natural calcium channel blocker that also increases nitric oxide production to relax the arteries and improve endothelial dysfunction.²⁸ These functions reduce the risk of high blood pressure.²⁹

Researchers have been studying the effect of magnesium on blood pressure for many years, but not always with the same results. One literature review of 44 human trials proposes that the dissimilar results are a function of study designs that are not uniformly matched between studies.³⁰ When a uniform subset of the 44 studies was combined, the scientists found a strong effect of magnesium against high blood pressure.

Low Sodium Diet Increases Risk of Heart Failure

In this video, James DiNicolantonio, Pharm.D, discusses the parallel between the rise of high blood pressure, diabetes and obesity with the reduction in salt consumption that began in the early 1900s. He goes on to explain that one of the body's ways of retaining salt is to increase insulin. With a low salt intake, your body becomes insulin resistant, which helps explain the rise in triglyceride levels in people who eat a low salt diet.

Guy Johnson, Ph.D., principal at Johnson Nutrition Solutions LLC, filed a petition with the FDA to request a qualified health claim for conventional foods and dietary supplements that contain 20% of the daily value of magnesium.³¹ He proposed, based on hundreds of studies and papers,³² that magnesium could reduce the risk of high blood pressure.

Six years later, in January 2022,³³ the FDA responded with a 42-page letter,³⁴ in which they concluded there wasn't enough evidence³⁵ after reviewing just 38 intervention studies. After documenting their reasons for discounting the results, the letter identified a secondary factor that must be met for the qualified health claim to be used — the conventional foods must also meet the “low sodium” criteria, writing:³⁶

“Sodium attracts water, and a high-sodium diet draws water into the bloodstream, which can increase the volume of blood and subsequently your blood pressure. High blood pressure or hypertension is a condition that makes the heart work too hard, and the high force of the blood flow can harm arteries and organs (such as the heart, kidneys, brain, and eyes).”

However, this is a rather simplistic view of how the body works. Sodium balance is impacted by several nutrients and kidney health. Your body uses magnesium, calcium³⁷ and potassium³⁸ to balance sodium, which in turn affects other aspects of your health, such as bone destiny, blood pressure, and heart and kidney health. When one level changes, it affects the others.

Sodium restriction has been a cornerstone of heart failure management. To move the focus to the other more damaging white crystal — sugar³⁹ — one paper⁴⁰ from Rush University Medical Center found salt restriction was associated with an increased risk of heart failure and death.

A second study⁴¹ demonstrated the risk of cardiovascular events decreased as the potassium level increased. There have been hundreds of studies across nearly every bodily system that shows maintaining overall health is not a singular function but, rather, a complex interaction between nutrients, enzymes and bodily systems.

Sleep Is Another Factor That May Raise Risk of Heart Disease

Your heart health depends on multiple factors, including how many hours of sleep you get each night. Researchers with the National Center for Cardiovascular Research^42,43 in Madrid, Spain found people who slept less than six hours each night were 27% more likely to have subclinical atherosclerosis than those who slept for seven or eight hours each night.

Subclinical atherosclerosis can trigger congestive heart failure as it increases the exercise load on the heart muscle. People who have fragmented sleep, which means they wake up often or have trouble falling asleep, also had a 34% increased risk of subclinical atherosclerosis compared to longer sleepers.⁴⁴ In the study, the researchers found there was a sweet spot since sleeping either too little or too much increased risk.

Women who slept for more than eight hours a night doubled the risk of subclinical atherosclerosis compared to those who slept seven or eight hours each night. The participants who were an average age of 46 years had a 5.9% risk of having a heart attack or stroke in the next 10 years or 17.7% in the next 30 years.⁴⁵ Yet, when the women slept for less than six hours a night, that risk increased to 6.9% for 10 years and 20.9% for 30 years.

“[T]his study emphasizes we have to include sleep as one of the weapons we use to fight heart disease — a factor we are compromising every day,” senior study author José M. Ordovás, Ph.D., said.⁴⁶ What’s more, he added, “This is the first study to show that objectively measured sleep is independently associated with atherosclerosis throughout the body, not just in the heart.”

The link between sleep and heart health is not new, and it could be that even seven hours is just barely enough. People who sleep less than seven hours a night have an increased risk of heart disease,⁴⁷ and this is true regardless of other factors that influence heart health, like age, weight, smoking and exercise habits.

People who struggle with sleep apnea, which causes frequent nighttime awakenings, often have heart trouble as well. Women with sleep apnea tend to have higher levels of the protein troponin T, which is a marker for heart damage and are more likely to have an enlarged heart,⁴⁸ which is a risk factor for heart failure. Too little sleep may also increase the inflammation in your body.

"Sleep-deprived people have higher blood levels of stress hormones and substances that indicate inflammation, a key player in cardiovascular disease. Even a single night of insufficient sleep can perturb your system,” according to Dr. Susan Redline, of the Division of Sleep Medicine at Harvard Medical School.⁴⁹

Lack of sleep also increases your risk of several health problems that take a toll on heart health, including high blood pressure, Type 2 diabetes and obesity, which are all risk factors for heart failure.

from Articles https://ift.tt/rf56jB8
via IFTTT

In 2021, McKinsey & Company, one of the largest consultants to corporations and governments worldwide, settled a lawsuit brought by 47 state attorneys general over its role in the U.S. opioid crisis. The firm agreed to pay $573 million in fines¹ for driving up sales of Purdue Pharma’s OxyContin painkiller, even as Americans were dying in droves.

Between 1999 and 2019, nearly 500,000 Americans died from overdoses involving opioid drugs,² and false advertising and bribery were at the heart of this tragedy. As reported by The New York Times:³

“McKinsey’s extensive work with Purdue included advising it to focus on selling lucrative high-dose pills, the records show, even after the drugmaker pleaded guilty in 2007 to federal criminal charges that it had misled doctors and regulators about OxyContin’s risks. The firm also told Purdue that it could ‘band together’ with other opioid makers to head off ‘strict treatment’ by the Food and Drug Administration.”

Worse Than We Thought

We now find out that the situation is even more corrupt than we previously thought. A U.S. House investigation^4,5,6 into McKinsey, based on materials obtained through the discovery process of this and other lawsuits, has revealed McKinsey was advising the FDA on the safety of opioids, while at the same time advising Purdue how to maximize sales.

In one instance, McKinsey wrote “scripts” for Purdue to use in its meeting with the FDA to discuss the safety of OxyContin in pediatric populations. In another, Jeff Smith, a senior McKinsey consultant, worked on a risk evaluation and mitigation strategy (REMS) for OxyContin while simultaneously advising the FDA about the drug’s safety.⁷

As noted by investigative journalist Paul Thacker,⁸ “Just think about that for a moment — for years McKinsey played both cop and robber.” As reported by The New York Times, April 13, 2022:⁹

“Since 2010, at least 22 McKinsey consultants have worked for both Purdue and the FDA, some at the same time, according to the committee’s 53-page report ...

The firm provided no evidence to the committee that it had disclosed the potential conflicts of interest as required under federal contracting rules — an ‘apparent violation,’ the report said.

McKinsey also allowed employees advising Purdue to help shape materials that were intended for government officials and agencies, including a memo in 2018 prepared for Alex M. Azar II, then the incoming secretary of health and human Services under President Donald J. Trump.

References to the severity of the opioid crisis in a draft version of the memo, the documents show, were cut before it was sent to Mr. Azar.

‘Today’s report shows that at the same time the FDA. was relying on McKinsey’s advice to ensure drug safety and protect American lives, the firm was also being paid by the very companies fueling the deadly opioid epidemic to help them avoid tougher regulation of these dangerous drugs,’ Representative Carolyn Maloney, the New York Democrat who chairs the committee, said in a statement ...

A bipartisan group of lawmakers last month introduced legislation¹⁰ aimed at preventing conflicts of interest in federal contracting, citing McKinsey’s experience with Purdue and the FDA.”

The FDA, in response, has stated that it “relies on its contractors to assess and report potential conflicts of interest,” The New York Times reports.¹¹ In other words, it’s just pointing fingers and refusing to take responsibility for working with advisers that clearly could, and should, be suspected of having ulterior motives, based on their client base.

Isn’t it obvious that McKinsey, working to improve sales for its opioid-making clients, might give the FDA biased advise on behalf of those clients? Remarkably, in October 2021, the FDA wrote¹² to senators claiming they had no idea McKinsey was even working for Purdue, and didn’t find out about it until media reported it in early 2021.

It seems beyond irrationally foolish that the press could find out about it, but not the FDA — somewhat like the head of the CDC, Dr. Rochelle Walensky, going on CNN and quoting Pfizer press releases as factual data.

McKinsey Advised FDA on Opioid Safety

The FDA hired McKinsey as an adviser in 2011. The company worked with the FDA office overseeing drug companies plans to monitor safety of risky products such as opioids, and internal documents show that, on multiple occasions, McKinsey promoted its FDA connections when pitching services to its pharmaceutical clients.¹³

For example, in a 2009 sales pitch, McKinsey wrote that it provided direct support to regulators, “and as such have developed insights into the perspectives of the regulators themselves.”¹⁴

In a 2014 email to Purdue’s chief executive, McKinsey consultant Rob Rosiello wrote, “We serve the broadest range of stakeholders that matter for Purdue. One client we can disclose is the FDA, who we have supported for over five years.”¹⁵

Evidence also suggests McKinsey took “steps to limit material that could be subpoenaed” once Purdue was sued, The New York Times reports.¹⁶ In one instance, printed hardcopies of slide decks were sent to Purdue instead of being emailed because they knew Purdue staff would be deposed and didn’t want their email correspondence to “get sucked into it.”

Did McKinsey Influence FDA Commissioner?

The Interim Majority Staff report¹⁷ by the Committee on Oversight and Reform, titled “The Firm and the FDA: McKinsey & Company’s Conflicts of Interest at the Heart of the Opioid Epidemic,” published April 13, 2022, also includes emails in which McKinsey employees claim to have influenced an opioid safety speech by then-FDA commissioner Dr. Scott Gottlieb.

Gottlieb denies the accusation, but the fact that McKinsey was working so intimately with the FDA means they certainly would have been capable of such influence. Gottlieb also has financial ties to the opioid industry, having received $45,000 in speaker’s fees from companies that manufacture and distribute opioids.¹⁸

In 2012, Gottlieb also wrote a Wall Street Journal essay, attacking the Drug Enforcement Administration (DEA) for pursuing the criminal activity of opioid distributors, saying it would burden patients, “including those with legitimate prescriptions who may be profiled at the pharmacy counter and turned away.”¹⁹

Intent to Harm

What we have here is a picture of gross conflicts of interest with an apparent intent to harm. Purdue Pharma was as crooked as they come, conducting sham studies and bribing doctors to prescribe its highly addictive opioid, while its consultant, McKinsey advised the FDA on the drug’s safety.

At the same time, Purdue also worked with the Publicis Groupe — the largest PR company in the world as of November 2021²⁰ — which funded the startup of NewsGuard, a “fact checking” group that rates websites on criteria of “credibility” and “transparency.” In April 2021, Publicis partnered with NewsGuard specifically “to fight the ‘infodemic’ of misinformation about COVID-19 and its vaccines.”²¹

NewsGuard’s health-related service, HealthGuard,²² is also partnered with the Center for Countering Digital Hate (CCDH) — a progressive U.K.-based cancel-culture leader²³ with extensive ties to government and global think tanks that has labeled people questioning the COVID-19 vaccine as “threats to national security.”

At the beginning of May 2021, the Massachusetts attorney general filed a lawsuit^24,25 against Publicis Health, accusing the Publicis subsidiary of helping Purdue create the deceptive marketing materials used to mislead doctors into prescribing OxyContin.^26,27,28,29

Like Purdue, Publicis also cashed in on the opioid addiction it helped create by pitching its services to organizations working to end addiction. As reported by Forbes,³⁰ the agency “won the account to work on drugfree.org after touting how it’s been ‘immersed in the evolving national opioid medication dialogue going on between pharma companies, the government and FDA, and the public via inside access as a trusted and informed consulting partner.’”

So, to summarize, Purdue knew the dangers of its drug, covered them up, hired FDA insiders to advise its sales strategy and influence the FDA, and is connected with a PR company that had the ability to suppress and censor negative news to manage its marketing. It’s hard to describe this scheme as anything but intentional mass murder.

The Spin Doctors

The reality may even be worse, and much larger, than that, seeing how Publicis is also a partner of the World Economic Forum (WEF),³¹ which is leading the call for a “reset” of the global economy and a complete overhaul of our way of life.³²

As detailed in the featured video, Publicis’ fingerprints can be found throughout the net of censorship and misdirection that is now being cast across the digital landscape. As the No. 1 PR company in the world, Publicis has just the right credentials and influence to pull off a deception of this size.

It’s part of an enormous network that includes international drug companies, fact checkers and credibility raters, Google, Microsoft, public libraries, schools, the banking industry, the U.S. State Department and Department of Defense, the World Health Organization and Disney, just to name a few. As noted by investigative reporter David Marks in “How PR Giant Publicis Promotes Greed, Deception on Behalf of World’s Most Powerful”:³³

“The essential skill of these expert spin doctors is their ability to fabricate a favorable interpretation of damaging information or activity or diminish the impact of the truth.

Through tried and true psychological ploys, repetition of false information or casting doubt on factual realities, ad agencies and PR firms target those who need to be influenced on behalf of their clients ...

An examination of one of the largest entities neck-deep in managing these mass psychological operations reveals the depth of the dysfunction afflicting the planet. The vast activities of the Publicis Groupe demonstrate how the tentacles of greed, profit and privilege connect the catastrophic agendas of the most powerful enterprises on Earth ...

Using sophisticated social psychology and incorporating the cutting edge of artificial intelligence, Publicis PR experts are masters of damage control, the manipulation of words and people, and of selling the unsellable. Publicis is organizing influential activities worldwide, overtly revealing its mission and priorities.

... [Its] website reveals who actually benefits from the company's services: ‘The entire Publicis Groupe transformation was designed to put clients at the center of all we do. Their needs and objectives drive the solutions we provide in order to help them win and grow’ ...

In considering the range of activities Publicis engages in, the dots are so close there is no need to connect them. The PR giant's methodology is transparent.

Whether promoting opioids or pushing vaccines, rebranding status quo profiteering as a Great Reset, supporting cigarette sales, disguising the true nature of the fossil fuel industry, increasing soft drink consumption or covering for assassinations — Publicis has all the skills and facilities to create whatever fabrications are needed to sell products and influence how their wealthy collaborators are viewed.

The Publicis Groupe and its allies are at the hub of a worldwide insidious, destructive disinformation campaign, relying on the duplicitous ways of advertising and public relations in the loyal service of clients.”

A Plan to Drug the Useless Eaters?

As a WEF partner and global PR machine for some of the most powerful industries on the planet, it seems reasonable to assume Publicis is helping to coordinate the WEF’s Great Reset agenda. Sadly, that includes not only the management and control of the peoples of the earth, but also the elimination of “undesirables.”

In a 2015 interview (video above), Yuval Noah Harari, a history professor and adviser to WEF founder Klaus Schwab, discussed what Schwab refers to as The Fourth Industrial Revolution (i.e., transhumanism), noting that we’re now learning to “produce bodies and minds” (meaning augmented bodies, and cloud and artificial intelligence-connected minds) and that one of the greatest challenges we face will be what to do with all the people that have become obsolete in the process.

How will unaugmented people find meaning in life when they’re basically “useless, meaningless”? How will they spend their time when there’s no work, no opportunity to move up in some kind of profession? His guess is that the answer will be “a combination of drugs and computer games.”

This raises a disturbing question. Was the opioid crisis the result of an intentional plan — a conspiracy in the literal sense of the word — to hook the masses on an addictive drug? This is purely speculative, of course, but it surely fits in with The Great Reset agenda as a whole.

If people are addicted, the drug and medical industries make money (and they’re without doubt part of The Great Reset network), and if people die, well, that’s in accordance with The Great Reset plan too, as they insist there are too many “useless eaters” on the planet, and they either must be managed or eliminated.

Publicis Is Part of the Global Monopoly

In closing, it’s worth noting that Publicis is partially owned by the Vanguard Group,³⁴ one of the two largest asset management firms in the world. Together with BlackRock, Vanguard has a hidden monopoly on global asset holdings and exerts control through their ownership of some 1,600 American companies.³⁵

Combined, BlackRock and Vanguard own nearly 90% of all S&P 500 firms.³⁶ To learn more about how Vanguard and BlackRock own just about everything in the world, and have monopoly control over all industries, check out the 45-minute video above, “Monopoly — Follow the Money.”

In short, the idea that there is competition in the marketplace is a cleverly disguised illusion. In reality, everything is controlled by a small group of asset managers that win no matter what. The end goal is to own and control all the world’s assets, which includes people.

The WEF slogan “You’ll Own Nothing and Be Happy” really summarizes The Great Reset plan for mankind. They will own everything; you will own nothing, not even your own body, and you’ll be too drugged up and lost in a make-believe computer game world to realize you’re a slave. If they can somehow make a profit from your useless existence, they’ll let you live. If they can’t, you’ll be eliminated. That’s really what the plan comes down to. 

The plan for global authoritarianism is advancing with each passing day, but all is not lost yet. By informing ourselves and sharing what we know with others, we can reach the critical mass needed to end their plan and take back control.

It’s going to require standing together, unified in favor of freedom and liberty. It’s going to require legal and legislative efforts to weed out the corruption and infiltration that has occurred throughout the corporate world and our governments. It’s going to require honest men and women to step into positions of power that they never wanted. It may take a lot of time and effort, but if we want our descendants to experience freedom, no price can be too great to pay.

from Articles https://ift.tt/md92UA8
via IFTTT